For qualified investors only · Not available to residents of India Investor Login  ·  ir@novemfund.com  ·  +66 81 489 8725
Strategy A · Core · 30–40%

QIB & Anchor Investments

Institutional participation in IPO anchor rounds, FPOs and public issues — entering at the allotment price the market has not yet set, with a defined liquidity horizon. This is the strategy behind the group’s exchange-verifiable 13-position anchor book.

Role in portfolio
Core return engineThe largest sleeve — repeatable, evidenced, comparatively liquid
Target allocation
30–40% of the portfolio
Opportunity
Priority anchor allocation in India’s IPO pipeline — 300+ SEBI approvals in queueAnchor windows give institutions allocation at issue price before public trading begins
What creates alpha
Issue-price entry plus selectionIn the group record, 90%+ of anchor exits were profitable and 60%+ exceeded 2× — selection, not the window alone, drives the outcome
Investment criteria
Fundamentals, valuation versus peers, governance, promoter quality, and post-listing liquidityInstitutional demand tested at entry — an under-subscribed book is a signal, not an opportunity
Typical holding period
Months, not yearsThe group anchor book averaged 132 days per position
Liquidity
Anchor lock-in per SEBI rules, then listed-market liquidityDefined windows make exit timing plannable
Primary risk
Listing below issue price during lock-inThe record’s one loss (−14%) is exactly this — shown unedited on the track-record page
Exit framework
Realised market exit within the defined windowPost-lock-in exit against the entry model’s target, with time-stop discipline
Research process
Full 14-stage pipeline compressed to the issue calendarThe 48-hour IC window exists because anchor books close fast
Catalysts
Listing pop, index/coverage inclusion, post-listing institutional demand
Evidence. Thirteen anchor positions, March 2024–February 2025, 12 of 13 profitable, +112% average absolute return, verifiable against public NSE Emerge and BSE SME filings — advisory record of the Equisculpt Ventures group, not this fund. Past performance is not indicative of future results.